On August 18, Argenx SE declined 3.83% overnight, trading at $950.02/share, with Turnover of $12,700.

Within the Biotechnology sector where Argenx SE belongs, the overall sector performance was mixed. Among individual stocks, Amgen up 0.39%, AbbVie up 0.04%, Vertex Pharmaceuticals up 0.75%, Gilead Sciences up 0.04%, Revolution Medicines down 0.03%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)